Is Immunomedics Worth 50% More?
After Immunomedics announced that it had appointed a new chief medical officer, Wells Fargo issued an analyst call implying upside of over 50%.
After Immunomedics announced that it had appointed a new chief medical officer, Wells Fargo issued an analyst call implying upside of over 50%.
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
What are investors, and patients, supposed to think when is launching a generic version of Diovan?
Pharmacy and drug store player Rite Aid now has a new street-high analyst target price from Credit Suisse.
The ALPS Medical Breakthroughs ETF debuted on the market Wednesday and is focused on research and development opportunities in biotechnology and pharmaceutical industries.
Out of 28 biotech stocks with market capitalization rates north of $300 million that were up 100% or more in 2014, seven of them were up 300% or more.
Flex Pharma Inc. has filed with the Securities and Exchange Commission (SEC) for its initial public offering.
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
One sector that could be poised to do well could be the biotech arena, and the team at RBC has five top stocks for investors to focus on as best ideas.
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
Juno Therapeutics debuted on the market Friday morning and has made a big splash.
Nurses are the most trusted workers in America, based on honesty and ethical standards. Doctors come in second.